C
Originally published by Capital Newstop
October 7, 2025
2h ago
Kenya bets on single-doze HPV vaccine in cervical cancer war
Director of Health, Dr. Patrick Amoth, said the transition will position Kenya as a leader in evidence-based immunization, simplifying logistics, cutting costs, and increasing vaccine coverage. - Kenya breaking news | Kenya news today | Capitalfm.co.ke..
✨ Key Highlights
Kenya is transitioning to a single-dose Human Papillomavirus (HPV) vaccine to combat cervical cancer and improve access for girls aged 10 to 14 years. This strategic shift, announced by the Ministry of Health, follows scientific recommendations validating the efficacy of one dose.
- Kenya aims to increase HPV vaccine coverage, which currently stands at over 60 per cent for the first dose, from 24 per cent in 2022.
- Director of Health, Dr. Patrick Amoth, stated the change will simplify logistics, cut costs, and boost coverage, positioning Kenya as a leader in evidence-based immunization.
- Cervical cancer remains the second most common cancer among Kenyan women, causing an estimated 3,211 deaths annually from 5,236 diagnoses, with potential to rise to 22 daily deaths by 2040 without stronger programs.
Continue Reading
Read the complete article from Capital News
